[Various principles of therapeutic tactics in epilepsy patients during pregnancy].
Forty-two epileptics were examined during pregnancy. According to the severity of the paroxysmal symptomatology, the authors identified three clinical groups: the first included patients with a therapeutic remission; the second, those with non-convulsive paroxysms; and the third group comprised patients with convulsive paroxysms. With due regard for impairments identified in the blood content of neurotransmitters, the patients received the multiple modality treatment, which included vitamins of group "B", potassium orotate, antihistamine drugs, the substitution of chloracon for phenobarbital and benzonal for diphenylhydantoin sodium; at the later stage of pregnancy the patients were given phenindamine tartrate. The use of the multiple modality treatment facilitated the cessation of attacks and served as the prevention of epileptic exacerbation in patients during the gestational and post-partal periods.
D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D004837:Epinephrine / Q000097:blood; D005260:Female; D006632:Histamine / Q000097:blood; D006801:Humans; D018377:Neurotransmitter Agents / Q000097:blood*; D009638:Norepinephrine / Q000097:blood; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000188:drug therapy*; D012701:Serotonin / Q000097:blood
D000927:Anticonvulsants; D018377:Neurotransmitter Agents; D012701:Serotonin; D006632:Histamine; D009638:Norepinephrine; D004837:Epinephrine
O nekotorykh printsipakh terapevticheskoĭ taktiki u bol'nykh épilepsieĭ v period beremennosti.